Andalusian Public Eye-Banks: a decade of continuous improvement.

OBJECTIVES: To show donation data, number of keratoplasties and the changes in transplant indications and techniques that occurred in Andalusia in the period from 2013 to 2022. MATERIALS AND METHODS: The present work is a retrospective and descriptive study that included all keratoplasties performed between January 2013 and December 2022 in Andalusia, as well as the evolution of the cornea donation and transplant activity of the public and private hospitals pertaining to the waiting list management system of the Public Health System of Andalusia. Transplants performed in private centers with corneas from outside Andalusia were excluded. RESULTS: Cornea donation activity in Andalusia in the decade 2013-2022 has experienced a growth of more than 126%, while overall transplant activity has increased by 157% in public hospitals. Penetrating keratoplasty has decreased from 83% in 2013 to 43% in 2022, while lamellar techniques have increased from 17% to 57% in this same period. Since 2018, more lamellar transplants are performed than penetrating transplants. Regarding indications, endothelial conditions already represent the first cause of transplantation. In 2022 alone, the public Andalusian Eye Banks evaluated 1,054 corneas and prepared 281 endothelial grafts. CONCLUSION: In the decade from 2013 to 2022 in Andalusia there has been an increase in donation activity and the number of keratoplasties. The public Eye Banks implementation in this period has played a key role in the widespread adoption of lamellar keratoplasty techniques and has enabled the transition to perform a greater number of lamellar keratoplasties compared to penetrating keratoplasty.

Long-term experience and Visual Acuity outcomes in Peters Anomaly cases.

PURPOSE: To report the results in a series of Peters Anomaly cases, and propose management and treatment approaches according to the alterations associated with each case. MATERIAL AND METHODS: A retrospective analysis was performed on the records of 27 patients (32 eyes) clinically diagnosed with Peters Anomaly. Each patient was subjected to different treatment modalities according to the type of Peters Anomaly, anywhere from medical follow-up clinics to a Penetrating Keratoplasty procedure (PKP). RESULTS: Of the 27 patients (32 eyes), 74% were male and 26% female, with 18.5% (5) being bilateral and 81.5% (22) unilateral. The mean number of years of follow-up was 10.2 years (Range: 3.5 to 18 years). The results of long-term VA correlate directly with the type of Peters Anomaly. For the total number of patients, the VA results were LogMAR 1.71 ±â€¯1.04. The results by groups were: Type I with only medical monitoring LogMAR 0.3 ±â€¯0, Type I with only Optical Iridectomy (OI) LogMAR 0.97 ±â€¯0.78, Type I with PKP LogMAR 1.22 ±â€¯0.97, Type II without a compromised posterior pole with PKP LogMAR 2.41 ±â€¯0.80, and Type II with a compromised posterior pole with PKP LogMAR 2.56 ±â€¯0.48. CONCLUSIONS: The result of VA and long-term corneal failure is directly related to the type of Peters Anomaly. Patients with Type I who only required medical follow-ups had the most favourable prognosis. Patients who underwent Peripheral Iridectomy followed and patients in which PKP was performed had an inferior prognosis.

Experiencia a largo plazo de pacientes con anomalía de Peters / Long-term experience and Visual Acuity outcomes in Peters Anomaly cases

ObjetivoComunicar los resultados de una serie de casos con anomalía de Peters, y proponer el manejo y sugerencias terapéuticas según alteraciones asociadas.Material y métodosSe analizaron las historias clínicas de 27 pacientes (32 ojos) con diagnóstico clínico de anomalía de Peters, los cuales fueron sometidos a diferentes tratamientos. Distintos parámetros y condiciones asociadas fueron evaluadas: presión intraocular (PIO), agudeza visual (AV), técnica quirúrgica y complicaciones postoperatorias.ResultadosDe los 27 pacientes (32 ojos), 74% sexo masculino y 26% femenino. El promedio de años de seguimiento fue de 10,2 años. La PIO preoperatoria fue de 23 ± 9,21 mmHg y al último control fue de 18,81 ± 7,45 mmHg. El resultado de AV a largo plazo se correlaciona directamente con el tipo de anomalía de Peters. Para el total los resultados de AV fueron LogMAR 1,71 ± 1,04 y por grupos: Tipo I sólo con seguimiento médico LogMAR 0,3 ± 0, Tipo I sólo con iridectomía periférica LogMAR 0,97 ± 0,78, Tipo I con queratoplastia penetrante (QPP) LogMAR 1,22 ± 0,97, Tipo II sin compromiso de polo posterior LogMAR 2,41 ± 0,80 y Tipo II con compromiso de polo posterior LogMAR 2,56 ± 0,48.ConclusionesEl resultado de AV y fracaso del injerto corneal a largo plazo se correlaciona directamente al tipo de anomalía de Peters, con mejor pronóstico la Tipo I en que se realizó sólo seguimiento médico, luego en los que se practicó iridectomía periférica, en los que se realizó QPP los que presentan peor pronóstico visual son con anomalía de Peters Tipo II con compromiso de polo posterior (p = 0.0087).

PurposeTo report the results in a series of Peters Anomaly cases, and propose management and treatment approaches according to the alterations associated with each case.Material and methodsA retrospective analysis was performed on the records of 27 patients (32 eyes) clinically diagnosed with Peters Anomaly. Each patient was subjected to different treatment modalities according to the type of Peters Anomaly, anywhere from medical follow-up clinics to a Penetrating Keratoplasty procedure (PKP).ResultsOf the 27 patients (32 eyes), 74% were male and 26% female, with 18.5% (5) being bilateral and 81.5% (22) unilateral. The mean number of years of follow-up was 10.2 years (Range: 3.5 to 18 years). The results of long-term VA correlate directly with the type of Peters Anomaly. For the total number of patients, the VA results were LogMAR 1.71 ± 1.04. The results by groups were: Type I with only medical monitoring LogMAR 0.3 ± 0, Type I with only Optical Iridectomy (OI) LogMAR 0.97 ± 0.78, Type I with PKP LogMAR 1.22 ± 0.97, Type II without a compromised posterior pole with PKP LogMAR 2.41 ± 0.80, and Type II with a compromised posterior pole with PKP LogMAR 2.56 ± 0.48.ConclusionsThe result of VA and long-term corneal failure is directly related to the type of Peters Anomaly. Patients with Type I who only required medical follow-ups had the most favourable prognosis. Patients who underwent Peripheral Iridectomy followed and patients in which PKP was performed had an inferior prognosis.

Prevalence and risk factors to develop ocular hypertension and glaucoma after penetrating keratoplasty.

OBJECTIVE: To determine the prevalence and factors associated with the development of ocular hypertension and glaucoma, in patients undergoing penetrating keratoplasty, in the Eye Clinic of the city of Bogotá. METHOD: A retrospective cross-sectional study was conducted, and 130 eyes of patients undergoing penetrating keratoplasty were analyzed at the Eye Clinic in Bogotá, between January 2015 and August 2018. Demographic and clinical data were obtained, and it was determined by bivariate analysis, the association factors and the prevalence of the pathology under study. RESULTS: Prevalence of ocular hypertension was 27.69% and glaucoma 10%. Average age 48.93 ± 18.63 years; higher frequency of presentation in men (61.5%). Statistically significant association factors were male sex (PR 2.59), presence of peripheral anterior synechiae (PR 1.83), history of trauma (PR 2.16), prior PK (PR 2.10) and graft failure (PR 2.04). Post-KP glaucoma only had statistically significant association with bullous keratopathy (PR 2.76). CONCLUSIONS: Ocular hypertension and glaucoma had a high prevalence after penetrating keratoplasty, and the association factors were similar to those reported in other international studies. Knowing these factors, allows focusing surveillance and treatment in these patients to avoid blindness due to damage of the optic nerve or corneal graft.

Prevalencia y factores de riesgo para desarrollar hipertensión ocular y glaucoma posterior a queratoplastia penetrante / Prevalence and risk factors to develop ocular hypertension and glaucoma after penetrating keratoplasty

Objetivo Determinar la prevalencia y los factores asociados con el desarrollo de la hipertensión ocular (HTO) y el glaucoma, en los pacientes sometidos a queratoplastia penetrante (QPP), en la Clínica de Ojos de la ciudad de Bogotá. Método Se realizó un estudio retrospectivo de corte transversal y se analizaron 130 ojos de pacientes sometidos a QPP, en la Clínica de Ojos de la ciudad de Bogotá, entre enero del 2015 y agosto del 2018. Se obtuvieron datos demográficos y clínicos y se determinó mediante el análisis bivariado los factores de asociación y la prevalencia de la patología a estudio. Resultados Prevalencia de HTO del 27,69% y glaucoma del 10%. Edad promedio 48,93 ± 18,63 años; frecuencia de presentación mayor en hombres (61,5%). Los factores de asociación estadísticamente significativos fueron el sexo masculino (PR 2,59), presencia de sinequias anteriores periféricas (PR 1,83), antecedente de trauma (PR 2,16), QPP previa (PR 2,10) y fracaso del injerto (PR 2,04). El glaucoma de la queratoplastia post penetrante (post-QPP) únicamente tuvo asociación estadísticamente significativa con la queratopatía bullosa (PR 2,76). Conclusiones La HTO y el glaucoma tuvieron una alta prevalencia posterior a QPP y los factores de asociación fueron similares a los reportados en otros estudios internacionales. Conocer estos factores permite enfocar la vigilancia y el tratamiento en estos pacientes para evitar la ceguera por daño del nervio óptico o del injerto corneal (AU)

Objective To determine the prevalence and factors associated with the development of ocular hypertension and glaucoma, in patients undergoing penetrating keratoplasty, in the Eye Clinic of the city of Bogotá. Method A retrospective cross-sectional study was conducted, and 130 eyes of patients undergoing penetrating keratoplasty were analyzed at the Eye Clinic in Bogotá, between January 2015 and August 2018. Demographic and clinical data were obtained, and it was determined by bivariate analysis, the association factors and the prevalence of the pathology under study. Results Prevalence of ocular hypertension was 27.69% and glaucoma 10%. Average age 48.93 ± 18.63 years; higher frequency of presentation in men (61.5%). Statistically significant association factors were male sex (PR 2.59), presence of peripheral anterior synechiae (PR 1.83), history of trauma (PR 2.16), prior PK (PR 2.10) and graft failure (PR 2.04). Post-KP glaucoma only had statistically significant association with bullous keratopathy (PR 2.76). Conclusions Ocular hypertension and glaucoma had a high prevalence after penetrating keratoplasty, and the association factors were similar to those reported in other international studies. Knowing these factors, allows focusing surveillance and treatment in these patients to avoid blindness due to damage of the optic nerve or corneal graf (AU)

Evaluation of the quality of life related to vision after penetrating keratoplasty. / Evaluación de la calidad de vida relacionada con la visión posterior a queratoplastia penetrante.

INTRODUCTION: Organ and tissue donation and transplantation represent the most important therapeutic advance of current times. The cornea is, by far, one of the most transplanted tissues worldwide due to the immune privilege of this tissue, as well as the advances in microsurgery, existence of cornea banks, preservation of corneas, and use of anti-rejection therapy. However, many patients with successful corneal transplants (with clear corneas) experience poor vision in the post-operative period due to irregular astigmatism, or other complications. OBJECTIVE: To evaluate the quality of life related to vision in patients undergoing penetrating keratoplasty. MATERIAL AND METHODS: A cross-analytical study including patients with a history of penetrating keratoplasty, over 18years of age, and at least 6months after surgery. The patients answered the Visual Function Questionnaire25 (VFQ-25) of visual function, a tool validated for use in Spanish, in which the higher the score, the better the quality of life. RESULTS: Thirty patients (20men and 10women), with a mean age of 61.2±18.7years, were included. The time of evolution after the transplant was 17.7±4months. The total quality of life score was 74.9±21.9, with significance in visual acuity (P<.001), and the presence of systemic comorbidities (P=.018). There was no significance between the transplant reason (P=.098) or ocular comorbidities (P=.119). CONCLUSION: The results suggest that visual acuity, as well as the presence of systemic comorbidities, has a significant impact on quality of life.

Early Penetrating Keratoplasty after interface fungal keratitis in Descemet Membrane Endothelial Keratoplasty. / Queratoplastia penetrante temprana después de queratitis fúngica de la interface en la queratoplastia endotelial de la membrana de Descemet.

In this case-report we describe the first reported case of early-onset fungal interface keratitis (IK) after Descemet Membrane Endothelial Keratoplasty (DMEK) successfully treated with penetrating keratoplasty (PK) during the active stage of infection. A patient with graft failure after Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) was operated on with DMEK. Donor rim culture and broth were positive for Candida albicans. Several interface infiltrates were confirmed and localized using anterior segment optical coherence tomography. Three days after diagnosis, observing clear signs of intraocular infection, the graft was removed with simultaneous washed-up of anterior chamber with fluconazole 1% followed by a PK and intrastromal corneal injections of fluconazole. A best-corrected visual acuity of 20/20 was achieved. This case highlights the importance of analysing every donor rim and broth, despite the patient doesn't show any symptoms or signs during the post-operative period. PK is a viable treatment option in early-onset interface keratitis.

Queratoplastia penetrante con fines ópticos. Presentación de cuatro casos / Penetrating keratoplasty with optical aims. Presentation of four cases

RESUMEN La queratoplastia penetrante ha sido el procedimiento empleado, de forma casi universal, para el tratamiento de las patologías corneales que afectan de forma irreversible a la visión. Se reportaron 4 casos clínicos de pacientes con afecciones corneales con compromiso visual severo, dado por visión de cuenta dedos y percepción luminosa. Luego de la evaluación completa en cada caso, se decidió realizar la queratoplastia penetrante con fines ópticos, con el objetivo de recuperar la transparencia de la córnea y la calidad visual. No existieron complicaciones transquirúrgicas y fueron seguidos según protocolo de evaluación postoperatoria de trasplante corneal. Los resultados y evaluación fueron satisfactorios, al año mantenían la transparencia del injerto y se logró mejoría considerable de la agudeza visual (AU).

ABSTRACT Penetrating keratoplasty has been a procedure used, almost universally, to treat corneal diseases affecting vision in an irreversible way. Four clinical cases are reported of patients with corneal affections severely compromising vision, given by short vision and luminous perception. After completely evaluating each case, the authors decided to perform the penetrant keratoplasty with optical aims, to recover cornea transparency and the vision quality. There were not transurgical complications and the patients were followed up according to the protocols of post-surgery evaluation of corneal graft. The results and evaluation were satisfactory; after a year, the transparency of the graft was maintained and visual acuity substantially improved (AU).

Pediatric penetrating keratoplasty and graft rejection: experience at the Hospital Infantil de México Federico Gómez.

Background: Penetrating keratoplasty (PK) is a challenging surgical ocular procedure indicated for some pediatric patients with vision-threatening corneal disease damage. Pediatric PK is reserved for cases with advanced pathology or dysfunction as rejection and failure rates greatly supersede the rates of adult PK. The objective was to identify factors associated with graft rejection and failure amongst Mexican children undergoing primary PK for different indications. Methods: A retrospective review of consecutive pediatric PK medical records was conducted between 2001 and 2015 at the Hospital Infantil de México Federico Gómez. Graft survival was calculated using the Kaplan-Meier survival method. Results: During the 15 years of study, 67 eyes of 57 patients underwent PK. The mean age at the time of surgery was 11 years. The mean follow-up duration was 44 months. Keratoconus was the most common indication for PK (61%) followed by herpetic keratitis (15%) and other corneal dystrophies (10%). Mean graft survival time was 45.6 months (95% confidence interval 31.8-58.4 months, standard deviation = 0.069), with a survival rate of 70% at 1 year. Univariate Cox proportional hazard showed that being < 9 years of age at the time of the surgery (p = 0.023) and corneal dystrophies (p = 0.04) were prognostic factors for corneal rejection. Five eyes of five patients developed graft failure. Conclusions: Pediatric PK patients commonly experience graft rejection, which need to be promptly diagnosed and treated to minimize permanent damage. The age at the time of surgery and congenital corneal opacities is factors associated with a higher risk of rejection and failure.

Introducción: La queratoplastia penetrante (QP) es un procedimiento quirúrgico indicado en algunos pacientes pediátricos con daño corneal con riesgo de fracaso que amenaza la visión. El objetivo del presente trabajo fue identificar los factores asociados a rechazo y fallo del injerto corneal en niños sometidos a QP. Métodos: Serie de casos de pacientes sometidos a QP en el Hospital Infantil de México Federico Gómez entre 2001 y 2015. La sobrevida del injerto fue calculada por el método de estimación de la función de supervivencia Kaplan­Meier. Resultados: Durante 15 años de estudio, 67 ojos de 57 pacientes fueron sometidos a QP. El promedio de edad de los pacientes al tiempo de la cirugía fue de 11 años. El seguimiento promedio fue de 44 meses. El queratocono fue la indicación más común de QP (61%), seguido de queratitis herpética (15%) y otras distrofias corneales (10%). El tiempo promedio de sobrevida fue 45.6% (intervalo de confianza [IC] 95%: 31.8-58.4 meses, desviación estándar [DS] = 0.069), con una tasa de sobrevida del 70% a 1 año. El riesgo proporcional de Cox univariado mostró que una edad < 9 años al momento de la cirugía (p = 0.023) y distrofias corneales (p = 0.04) son factores pronóstico para el rechazo corneal. Cinco ojos de cinco pacientes desarrollaron falla del injerto. Conclusiones: El rechazo del injerto en QP en pacientes pediátricos es común y puede ser resuelto satisfactoriamente en casi todos los casos con diagnóstico y tratamiento. La edad al momento de la cirugía y las opacidades corneales congénitas son factores asociados con el rechazo y fallo.

Queratoplastia penetrante con y sin terapia antiviral en la queratopatía herpética / Penetrating keratoplasty with and without antiviral therapy in herpetic keratopathy

RESUMEN Objetivo: Identificar el resultado óptico o terapéutico de la queratoplastia penetrante en pacientes con queratopatía herpética. Métodos: Se realizó una investigación descriptiva, transversal, donde se expusieron los resultados del alcance de la queratoplastia penetrante por queratopatía herpética, operados en el Hospital Clínico Quirúrgico "Hermanos Ameijeiras", de La Habana. Resultados: La muestra fue de 33 queratoplastias penetrantes. Con fines ópticos sumaron 24 (72,7 por ciento) y tectónicas 9 (27,3 por ciento). En 5 de estas la agudeza visual fue menor o igual a 0,3. En el total de la muestra, 9 opacificaron, 11 sufrieron complicaciones posquirúrgicas, 8 recurrieron en queratoplastias penetrantes ópticas y 6 en queratoplastias penetrantes terapéuticas. Se rechazaron 7 queratoplastias penetrantes ópticas (33,3 por ciento) y 4 queratoplastias penetrantes terapéuticas (4 por ciento). Presentaron complicaciones 5 (25 por ciento) con queratoplastias penetrantes ópticas y 6 (55,6 por ciento) con queratoplastias penetrantes terapéuticas. En el posquirúrgico 22 (66,6 por ciento) tenían agudeza visual mayor o igual a 0,3 (p= 0,0000). Conclusiones: La inactividad de la enfermedad viral corneal beneficia el pronóstico del injerto por queratopatía herpética en las opacidades de las queratoplastias con fines ópticos. Queda demostrado que el uso de antivirales pre y posoperatorios disminuye la recidiva de la enfermedad herpética sobre el injerto y el rechazo, al lograr mejor agudeza visual y mayor viabilidad. La severidad inflamatoria posquirúrgica se asocia con la enfermedad viral activa o afección de origen inmune al realizar el trasplante, conexos a las complicaciones post queratoplastia(AU)

ABSTRACT Objective: Identify the optical or therapeutic outcome of penetrating keratoplasty in patients with herpetic keratopathy. Methods: A descriptive cross-sectional study was conducted in which a presentation was made of the results of the scope of penetrating keratoplasties for herpetic keratopathy performed at Hermanos Ameijeiras Clinical Surgical Hospital in Havana. Results: The sample was 33 penetrating keratoplasties: 24 optical (72.7 percent) and 9 tectonic (27.3 percent). Visual acuity was lower than or equal to 0.3 in 5 of them. Of the total sample, 9 opacified, 11 had postoperative complications, 8 recurred in optical penetrating keratoplasties, and 6 in therapeutic penetrating keratoplasties. Rejection occurred in 7 optical penetrating keratoplasties (33.3 percent) and 4 therapeutic penetrating keratoplasties (4%). Complications were observed in 5 (25 percent) optical penetrating keratoplasties and 6 (55.6 percent) therapeutic penetrating keratoplasties. In the postoperative period 22 (66.6 percent) had a visual acuity greater than or equal to 0.3 (p= 0.0000). Conclusions: Inactivity of corneal viral disease benefits the prognosis of grafting due to herpetic keratopathy in opacities of optical keratoplasties. Pre- and postoperative antivirals were found to reduce the recurrence of herpetic disease on the graft and rejection, achieving better visual acuity and greater viability. Postoperative inflammatory severity is associated to an active viral disease or an immune disorder at the time of the grafting resulting in post keratoplasty complications(AU)

Resultados visuales en pacientes operados de queratoplastia lamelar anterior profunda versus queratoplastia penetrante en el queratocono / Visual results in patients operated of deep anterior lamellar keratoplasty versus penetrating keratoplasty in keratoconus

RESUMEN Objetivo: Comparar los resultados visuales de la queratoplastia lamelar anterior profunda versus la queratoplastia penetrante en el tratamiento quirúrgico del queratocono. Métodos: Se realizó un estudio analítico longitudinal prospectivo en 81 pacientes con queratocono, operados de queratoplastia penetrante y queratoplastia lamelar anterior profunda entre los años 2014 y 2018. Se evaluó la edad, el sexo, la agudeza visual corregida, la esfera, el cilindro y el equivalente esférico. Resultados: La media de edad en operados de queratoplastia lamelar anterior profunda fue 27,5 ± 10,0 años, y 33,2 ± 12,9 años en operados de queratoplastia penetrante. En ambos grupos predominó el sexo masculino: 62,5 por ciento en el grupo de queratoplastia lamelar anterior profunda y 63,3 por ciento en el de queratoplastia penetrante. La agudeza visual corregida poscirugía en operados de queratoplastia lamelar anterior profunda fue 0,8 ± 0,19; el cilindro refractivo -3,50 ± 1,50; el equivalente esférico -6,07 ± 3,61, SimK1 de 46,37 ± 2,47 dioptrías y SimK2, 43,05 ± 2,47 dioptrías. En la queratoplastia penetrante, la agudeza visual corregida fue 0,68 ± 0,19; el cilindro refractivo -2,77 ± 0,98 dioptrías; el equivalente esférico -3,68 ± 1,56 dioptrías, SimK1 y SimK2 de 44,58 ± 2,77 dioptrías y 41,40 ± 2,93 dioptrías respectivamente. Conclusiones: Los resultados refractivos son similares en ambas técnicas quirúrgicas(AU)

ABSTRACT Objective: Compare the visual results of deep anterior lamellar keratoplasty versus penetrating keratoplasty in the surgical treatment of keratoconus. Methods: A longitudinal analytical prospective study was carried out in 81 patients with keratoconus, operated of penetrating keratoplasty and deep anterior lamellar keratoplasty between the years 2014 and 2018. The variables analyzed were the age, the sex, the corrected visual sharpness, the sphere, the cylinder and the spherical equivalent. Results: The average of age in operated patients of deep anterior lamellar keratoplasty was 27,5 ± 10,0 years, and 33,2 ± 12,9 years in operated of penetrating keratoplasty. In both groups the masculine sex predominated: 62,5 percent in the group of deep anterior lamellar keratoplasty and 63,3 percent in penetrating keratoplasty. The corrected visual sharpness in operated of queratoplastia lamelar previous deep was 0,8 ± 0,19; the refractive cylinder -3,50 ± 1,50; the spherical equivalent -6,07 ± 3,61, SimK1 of 46,37 ± 2,47 dioptres and SimK2, 43,05 ± 2,47 dioptres. In the penetrating keratoplasty, the corrected visual sharpness was 0,68 ± 0,19; the refractive cylinder -2,77 ± 0,98 dioptres; the spherical equivalent -3,68 ± 1,56 dioptres, SimK1 and SimK2 of 44,58 ± 2,77 dioptres and 41,40 ± 2,93 dioptres respectively. Conclusions: The refractive results are similar in both surgical technicians(AU)

Seguridad de la queratoplastia lamelar anterior profunda versus queratoplastia penetrante en el tratamiento del queratocono / Safety of deep anterior lamellar keratoplasty versus penetrating keratoplasty in the treatment of keratoconus

RESUMEN Objetivo: Comparar las complicaciones de la queratoplastia lamelar anterior profunda y la queratoplastia penetrante en el tratamiento quirúrgico del queratocono. Métodos: Se realizó un estudio analítico longitudinal prospectivo en 81 pacientes operados de queratoplastia con diagnóstico de queratocono. Las variables analizadas fueron el cilindro, el componente esférico, la densidad celular y las complicaciones en el pre- y en el posoperatorio. Para el análisis estadístico se utilizó la prueba t de Student para la comparación de medias para datos pareados en el caso de dos valores promedios. Resultados: En el paciente operado de queratoplastia lamelar anterior profunda el cilindro fue -3,50 ± 1,50; y en la queratoplastia penetrante el resultado fue de -2,77 ± 0,98. La densidad celular posoperatoria fue de 2 333,6 cel/mm2 en la queratoplastia lamelar anterior profunda y de 2 269,3 cel/mm2 en la queratoplastia penetrante. En la queratoplastia lamelar anterior profunda el 75 por ciento evolucionó sin complicaciones, y el 82,7 por ciento presentó queratoplastia penetrante. Las complicaciones más frecuentes para la queratoplastia lamelar anterior profunda fueron la microperforación, el glaucoma secundario y el síndrome de Urretz-Zavalia (12,5 por ciento cada uno) y en la queratoplastia penetrante el rechazo endotelial (18,2 por ciento) y el defecto epitelial (9,1 por ciento). Conclusiones: En la queratoplastia lamelar anterior profunda la pérdida celular endotelial es más lenta en el primer año y las complicaciones son escasas(AU)

ABSTRACT Objetive: Compare the complications of deep anterior lamellar keratoplasty and penetrating keratoplasty in the surgical treatment of keratoconus. Methods: An analytical prospective longitudinal study was conducted of 81 patients undergoing keratoplasty and diagnosed with keratoconus. The variables analyzed were cylinder, spherical component, cell density, and preoperative and postoperative complications. Statistical analysis was based on Student's t-test for comparison of means for paired data in the event of two average values. Results: Cylinder was -3.50 ± 1.50 for deep anterior lamellar keratoplasty and -2.77 ± 0.98 for penetrating keratoplasty. Postoperative cell density was 2 333.6 cell/mm2 for deep anterior lamellar keratoplasty and 2 269.3 cell/mm2 for penetrating keratoplasty. 75 percent of the patients undergoing deep anterior lamellar keratoplasty and 82.7 percent of those undergoing penetrating keratoplasty evolved without any complication. The most common complications were microperforation, secondary glaucoma and Urretz-Zavalia syndrome (12.5 percent each) for deep anterior lamellar keratoplasty, and endothelial rejection (18.2 percent) and epithelial defect (9.1 percent) for penetrating keratoplasty. Conclusions: In deep anterior lamellar keratoplasty endothelial cell loss is slower in the first year and complications are scant(AU)

Pediatric penetrating keratoplasty and graft rejection: experience at the Hospital Infantil de México Federico Gómez / Queratoplastia penetrante pediátrica y rechazo corneal: experiencia en el Hospital Infantil de México Federico Gómez

Abstract Background: Penetrating keratoplasty (PK) is a challenging surgical ocular procedure indicated for some pediatric patients with vision-threatening corneal disease damage. Pediatric PK is reserved for cases with advanced pathology or dysfunction as rejection and failure rates greatly supersede the rates of adult PK. The objective was to identify factors associated with graft rejection and failure amongst Mexican children undergoing primary PK for different indications. Methods: A retrospective review of consecutive pediatric PK medical records was conducted between 2001 and 2015 at the Hospital Infantil de México Federico Gómez. Graft survival was calculated using the Kaplan–Meier survival method. Results: During the 15 years of study, 67 eyes of 57 patients underwent PK. The mean age at the time of surgery was 11 years. The mean follow-up duration was 44 months. Keratoconus was the most common indication for PK (61%) followed by herpetic keratitis (15%) and other corneal dystrophies (10%). Mean graft survival time was 45.6 months (95% confidence interval 31.8-58.4 months, standard deviation = 0.069), with a survival rate of 70% at 1 year. Univariate Cox proportional hazard showed that being < 9 years of age at the time of the surgery (p = 0.023) and corneal dystrophies (p = 0.04) were prognostic factors for corneal rejection. Five eyes of five patients developed graft failure. Conclusions: Pediatric PK patients commonly experience graft rejection, which need to be promptly diagnosed and treated to minimize permanent damage. The age at the time of surgery and congenital corneal opacities is factors associated with a higher risk of rejection and failure.

Resumen Introducción: La queratoplastia penetrante (QP) es un procedimiento quirúrgico indicado en algunos pacientes pediátricos con daño corneal con riesgo de fracaso que amenaza la visión. El objetivo del presente trabajo fue identificar los factores asociados a rechazo y fallo del injerto corneal en niños sometidos a QP. Métodos: Serie de casos de pacientes sometidos a QP en el Hospital Infantil de México Federico Gómez entre 2001 y 2015. La sobrevida del injerto fue calculada por el método de estimación de la función de supervivencia Kaplan–Meier. Resultados: Durante 15 años de estudio, 67 ojos de 57 pacientes fueron sometidos a QP. El promedio de edad de los pacientes al tiempo de la cirugía fue de 11 años. El seguimiento promedio fue de 44 meses. El queratocono fue la indicación más común de QP (61%), seguido de queratitis herpética (15%) y otras distrofias corneales (10%). El tiempo promedio de sobrevida fue 45.6% (intervalo de confianza [IC] 95%: 31.8-58.4 meses, desviación estándar [DS] = 0.069), con una tasa de sobrevida del 70% a 1 año. El riesgo proporcional de Cox univariado mostró que una edad < 9 años al momento de la cirugía (p = 0.023) y distrofias corneales (p = 0.04) son factores pronóstico para el rechazo corneal. Cinco ojos de cinco pacientes desarrollaron falla del injerto. Conclusiones: El rechazo del injerto en QP en pacientes pediátricos es común y puede ser resuelto satisfactoriamente en casi todos los casos con diagnóstico y tratamiento. La edad al momento de la cirugía y las opacidades corneales congénitas son factores asociados con el rechazo y fallo.

Úlcera corneal grave secundaria a artritis reumatoide / Severe corneal ulcer secondary to rheumatoid arthritis

Introducción: la artritis reumatoide es una enfermedad multisistémica, inflamatoria, crónica, de origen desconocido. Aproximadamente 20-35 por ciento de los pacientes que la padecen presentan manifestaciones oculares.Objetivo: describir las características de la úlcera corneal grave secundaria a artritis reumatoide en una paciente.Presentación del caso: paciente femenina, de 50 años de edad, con antecedentes de artritis reumatoide y queratoconjuntivitis seca grave. Presentó una lesión ulcerativa corneal paracentral inferotemporal de 4 mm que afectaba el estroma del ojo derecho. La muestra tomada para examen directo y cultivo resultó positiva para Staphylococcus aureus. Se trató con colirios antibióticos fortificados de amplio espectro, antinflamatorio no esteroideo y midriático. Posteriormente, apareció infección micótica sobreañadida y descemetocele central con perforación. Se le realizó queratoplastia penetrante tectónica terapéutica, y retrasplante siete días después. Presentó rechazo al injerto con opacificación del trasplante y catarata total. Actualmente se encuentra en espera de la realización de queratoplastia penetrante óptica y operación de cataratas con implante de lente intraocular, para restablecer la transparencia corneal y mejorar su agudeza visual Conclusiones: la lesión ulcerativa corneal que presentó la paciente es frecuente en personas enfermas de artritis reumatoide. En su caso, como en la mayoría, no hubo respuesta favorable al tratamiento, por lo que debe ser sometida a queratoplastia penetrante óptica y operación de cataratas con implante de lente intraocular. El tratamiento precoz de las afecciones oculares contribuye a mejorar el pronóstico visual del paciente, por lo que se recomienda protocolizar el estudio oftalmológico periódico a todos los pacientes diagnosticados de artritis reumatoide(AU)

Introduction: rheumatoid arthritis is a multisystemic, inflammatory, chronic disease of unknown origin. Approximately 20-35 percent of patients who suffer from it present ocular manifestations.Objective: to describe the characteristics of secondary severe corneal ulcer to rheumatoid arthritis in a patient.Case presentation: female patient, 50 years old, with a history of rheumatoid arthritis and severe keratoconjunctivitis sicca. She presented a 4 mm inferotemporal paracentral corneal ulcerative lesion that affected the stroma of the right eye. The sample taken for direct examination and culture was positive for Staphylococcus aureus. She was treated with fortified broad-spectrum antibiotics, non-steroidal anti-inflammatory and mydriatic anti-inflammatory eye drops. Subsequently, an overlying fungal infection and central descemetocele with perforation emerged. She underwent therapeutic tectonic penetrating keratoplasty, and retransplanted seven days later. She presented rejection to the graft with opacification of the transplant and total cataract. She is currently awaiting the performance of optical penetrating keratoplasty and cataract surgery with intraocular lens implant, to restore corneal transparency and improve visual acuity.Conclusions: the corneal ulcerative lesion presented by the patient is frequent in patients with rheumatoid arthritis. In her case, as in the majority, there was no favorable response to treatment, so she should undergo optical penetrating keratoplasty and cataract surgery with intraocular lens implantation. The early treatment of ocular affections contributes to improve the visual prognosis of the patient, for which it is recommended to formalize the periodic ophthalmological study to all patients diagnosed with rheumatoid arthritis(AU)

Visual outcome of penetrating keratoplasty, deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty.

PURPOSE: A single-center, cross-sectional study was designed to assess and compare objective and subjective quality of vision of patients intervened with penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK) and Descemet membrane endothelial keratoplasty (DMEK). METHODS: Forty-six patients previously intervened with PK (22 eyes), DALK (7 eyes) and DMEK (17 eyes) were recruited. Visual evaluation included spherical and cylindrical refraction, distance corrected visual acuity (DCVA), photopic contrast sensitivity (CS), optical quality, measured with the HD Analyzer (objective scattering index [OSI], MTF cut-off and Strehl ratio), and ocular and corneal aberrometry, measured with the KR-1W Wavefront Analyzer. RESULTS: Statistically significant between-group differences were found in age (p=0.006, DMEK patients were older) and time since surgery (p<0.001, longest time for PK patients). No statistically significant differences were found in DCVA between the techniques. Between-group differences were encountered in CS at 12 (p=0.007) and 18 (p<0.001) cycles per degree, with DMEK and DALK obtaining the best and worst outcomes, respectively. Differences in optical quality were found between the techniques (OSI, p=0.004; MTF cut-off, p=0.048; Strehl ratio p=0.022), with DMEK displaying the best outcomes. Highest and lowest values in ocular and corneal aberrations were for DALK and DMEK patients, respectively. Between-group differences were found in corneal astigmatism (p<0.001; -3.31±2.00 D in PK; -2.68±0.94 D in DALK; -1.09±0.62 D in DMEK). CONCLUSION: Overall, DMEK proved superior over PK and DALK in terms of quality of vision, with PK offering slightly better outcomes than DALK in most visual function parameters under evaluation.

Desenlaces en pacientes operados con queratoprótesis boston tipo 1 en un centro oftalmológico especializado en la ciudad de Medellín / Outcomes in patients with boston type 1 keratoprosthesis in a specialized center in Medellín

Objetivo: reportar las características y descenlaces de pacientes con queratoprótesis Boston tipo 1. Diseño: estudio observacional descriptivo de corte transversal. Método: se incluyeron los pacientes operados con queratoprótesis Boston tipo 1 residentes en Colombia, mayores de 17 años, sin queratoprótesis previas y que tuviera más de 6 meses de seguimiento, para un total de 39 ojos de 39 pacientes. La cirugía se indicó en los casos con o sin queratoplastia previa que tuvieran agudeza visual (AV) igual o inferior a cuenta dedos y déficit de limbo bilateral o vascularización corneal profunda en más de 3 cuadrantes. Se recolectó y analizó la información de la historia clínica en forma retrospectiva y prospectiva. Las variables principales fueron: agudeza visual, retención del dispositivo y complicaciones. Se realizó un análisis univariado presentando los resultados en frecuencias absolutas y porcentajes para las variables categóricas y para las variables cuantitativas como promedio y desviación estándar (DE) si tienen distribución normal o como mediana y rango intercuartil si no tienen distribución normal. Resultados: La mediana de seguimiento fue de 53.5 meses (rango 6 meses a 10 años). La mayoría de pacientes (66.7%) habían tenido previamente queratoplastia penetrante. El diagnóstico de base fue en 53.8% condiciones no inflamatorias yen 46.2% condiciones inflamatorias. La AV preoperatoria en todos los ojos estaba entre percepción de luz y cuenta dedos; posterior a la cirugía el 97.4% tuvieron mejoría de la AV. Para el fi nal del seguimiento la AV permaneció mejor que la preoperatoria en 53.8%, fue igual a esta en 17.94% y peor que esta en 28.2%. Hubo necrosis periprostética en 28.2%, y 38.5% tuvieron recambio del dispositivo. Al final del seguimiento 89.7% de los pacientes tenían una queratoprótesis in-situ. Conclusión: la queratoprótesis Boston tipo 1 es una opción viable para mejorar la AV en pacientes con trasplantes de córnea fallidos o en quienes se prevé alta tasa de fallo o rechazo de este. En la gran mayoría de los pacientes se logra mejoría inicial significativa de la AV, la cual se mantiene al final del seguimiento en más de la mitad de ellos. Refinamientos progresivos en la técnica quirúrgica y el manejo postoperatorio disminuirán las complicaciones que llevan a la perdida visual progresiva

Purpose: to report characteristics and outcomes in patients with Boston type 1 keratoprosthesis. Design: observational descriptive cross-sectional study. Method: Patients with Boston type 1 queratoprosthesis who were living in Colombia, 17 years or older, without previous keratoprosthesis and with more than 6 months follow up were included, for a fi nal of 39 eyes from 39 patients. Surgery was indicated for those with or without previous keratoplasty who had visual acuity (VA) of counting fi ngers or worse and bilateral limbal stem cell deficiency or deep corneal vascularization in more than 3 quadrants. Information was collected retrospectively and prospectively from medical registries and was analyzed. Main variables were: visual acuity, device retention and complications. An univariate analysis was conducted and results are presented in absolute frequencies and percentages for categoric variables and for quantitative variables in average and standard deviation (SD) if they have normal distribution and in median and interquartile range if they do not have normal distribution. Results: Median follow up was 53.5 months (range 6 months to 10 years). Most patients (66.7%) had previous penetrating keratoplasty. Baseline diagnoses were in 53.8% non-infl ammatory conditions and in 46.2% inflammatory conditions. Preoperative VA ranged between light perception and counting fingers in all eyes; aft er surgery 97.4% had improvement in VA. By the end of follow up VA remained better than preoperative in 53.8%, was the same as preoperative in 17.94% and worse than preoperative in 28.2%. There was periprosthetic necrosis in 28.2%, and 38.5% had keratoprothesis exchange. At the end of follow up 89.7% of patients had a keratoprosthesis in-situ. Conclusion: Boston type 1 keratoprosthesis is a viable option to improve VA in patients with previously failed corneal transplants or in cases that anticipate bad prognosis for keratoplasty. In most patients there was a signifi cant initial improvement in vision, and more than half of them retained better than initial VA on their last follow up. Further refinements in surgical technique and postoperative care would decrease complications that lead to progressive visual loss.

Refractory aqueous misdirection syndrome: A possible complication of penetrating keratoplasty. / Síndrome de dirección inadecuada del humor acuoso refractario: una posible complicación de la queratoplastia penetrante.

CLINICAL CASE: An 85 year-old woman presented with a flat anterior chamber of the left eye, severe ocular hypertension, and a normal ultrasound examination in the day following a penetrating keratoplasty (PK). The clinical status did not respond to maximum medical therapy, laser posterior capsulotomy, anterior hyaloidotomy, and complete 23 G vitrectomy. The patient refused further intervention, and light perception was lost after 6 months of follow-up. DISCUSSION: This is the first report of refractory aqueous misdirection syndrome following primary PK. Despite maximum medical and surgical management efforts, aqueous misdirection syndrome subsequent to primary PK may have a catastrophic outcome.

Modificaciones corneales posqueratoplastia penetrante óptica / Corneal changes after penetrating optical keratoplasty

Objetivo: determinar las modificaciones de la córnea donante en el primer año de la posqueratoplastia. Métodos: se realizó un estudio descriptivo, longitudinal y prospectivo de serie de casos en 45 pacientes. Para el procesamiento de las variables se utilizó la prueba de Chi cuadrado con corrección de Yates asociada a pruebas de rangos con signos de Wilcoxon y la prueba de probabilidades exactas de Fischer. Resultados: el diagnóstico más frecuente fue la queratopatía bullosa (35,5 por ciento). La pérdida celular anual fue de 22,8 por ciento; el astigmatismo oblicuo con 61,5 por ciento y la media del cilindro queratométrico de 5,96. En microscopia confocal encontramos ausencia de fibras nerviosas (86,7 por ciento), presencia de queratocitos activados (22,2 por ciento) y haze (11,1 por ciento). Los injertos transparentes correspondieron al 82,2 por ciento. Observamos queratocitos activados en 80 por ciento de córneas no transparentes. El 33,3 por ciento de los leucomas corneales se opacificaron. La complicación más frecuente fue el glaucoma secundario (33,3 por ciento). El 100 por ciento de las úlceras corneales bacterianas evolucionaron a fallo del injerto. Conclusiones: la córnea posqueratoplastia presenta una pérdida celular endotelial anual de 22,8 por ciento, astigmatismo oblicuo, cilindro queratométrico entre 3-6 dioptrías, presencia de queratocitos activados y haze corneal como factores pronósticos de pérdida de transparencia del injerto. El leucoma corneal posúlcera, la queratopatía bullosa como diagnóstico preoperatorio y la úlcera corneal bacteriana como complicaciones provocan pérdida de transparencia del injerto(AU)

Objective: to determine the changes in the donor cornea after one year of keratoplasty. Methods: prospective, longitudinal and descriptive case series study conducted in 45 patients. For variable processing, the study used Yate's corrected Chi-square test associated to Wilcoxon's range test and to Fisher's exact test. Results: the most common diagnosis was bullous keratopathy (35.5 percent). The annual cell loss was 22.8 percent; oblique astigmatism with 61.5 percent and the mean of the keratometric cylinder was 5.96 percent. Using the confocal microscopy, we found lack of nervous fibers (86.7 percent), presence of activated keratocytes (22.2 percent) and haze (11.1 percent). Transparent grafts represented 82.2 percent. Activated keratocytes were observed in 80 percent of non-transparent corneas. In the study, 33.3 percent of corneal leukomas showed opacification. The most common complication was secondary glaucoma (33.3 percent). All the bacterial corneal ulcers evolved into failed graft. Conclusions: after keratoplasty, the cornea showed annual endothelial cell loss of 22.8 percent, oblique astigmatism, 3-6 diopter keratometric cylinder, presence of activated keratocytes and corneal haze as prognostic factors of loss of graft transparency. The post-ulcer corneal leukoma, bullous keratopathy as preoperative diagnosis and bacterial corneal ulcer as main complication cause loss of graft transparency(AU)

Modificaciones corneales posqueratoplastia penetrante óptica / Corneal changes after penetrating optical keratoplasty

Objetivo: determinar las modificaciones de la córnea donante en el primer año de la posqueratoplastia. Métodos: se realizó un estudio descriptivo, longitudinal y prospectivo de serie de casos en 45 pacientes. Para el procesamiento de las variables se utilizó la prueba de Chi cuadrado con corrección de Yates asociada a pruebas de rangos con signos de Wilcoxon y la prueba de probabilidades exactas de Fischer. Resultados: el diagnóstico más frecuente fue la queratopatía bullosa (35,5 por ciento). La pérdida celular anual fue de 22,8 por ciento; el astigmatismo oblicuo con 61,5 por ciento y la media del cilindro queratométrico de 5,96. En microscopia confocal encontramos ausencia de fibras nerviosas (86,7 por ciento), presencia de queratocitos activados (22,2 por ciento) y haze (11,1 por ciento). Los injertos transparentes correspondieron al 82,2 por ciento. Observamos queratocitos activados en 80 por ciento de córneas no transparentes. El 33,3 por ciento de los leucomas corneales se opacificaron. La complicación más frecuente fue el glaucoma secundario (33,3 por ciento). El 100 por ciento de las úlceras corneales bacterianas evolucionaron a fallo del injerto. Conclusiones: la córnea posqueratoplastia presenta una pérdida celular endotelial anual de 22,8 por ciento, astigmatismo oblicuo, cilindro queratométrico entre 3-6 dioptrías, presencia de queratocitos activados y haze corneal como factores pronósticos de pérdida de transparencia del injerto. El leucoma corneal posúlcera, la queratopatía bullosa como diagnóstico preoperatorio y la úlcera corneal bacteriana como complicaciones provocan pérdida de transparencia del injerto(AU)

Objective: to determine the changes in the donor cornea after one year of keratoplasty. Methods: prospective, longitudinal and descriptive case series study conducted in 45 patients. For variable processing, the study used Yate's corrected Chi-square test associated to Wilcoxon's range test and to Fisher's exact test. Results: the most common diagnosis was bullous keratopathy (35.5 percent). The annual cell loss was 22.8 percent; oblique astigmatism with 61.5 percent and the mean of the keratometric cylinder was 5.96 percent. Using the confocal microscopy, we found lack of nervous fibers (86.7 percent), presence of activated keratocytes (22.2 percent) and haze (11.1 percent). Transparent grafts represented 82.2 percent. Activated keratocytes were observed in 80 percent of non-transparent corneas. In the study, 33.3 percent of corneal leukomas showed opacification. The most common complication was secondary glaucoma (33.3 percent). All the bacterial corneal ulcers evolved into failed graft. Conclusions: after keratoplasty, the cornea showed annual endothelial cell loss of 22.8 percent, oblique astigmatism, 3-6 diopter keratometric cylinder, presence of activated keratocytes and corneal haze as prognostic factors of loss of graft transparency. The post-ulcer corneal leukoma, bullous keratopathy as preoperative diagnosis and bacterial corneal ulcer as main complication cause loss of graft transparency(AU)

Unilateral persistent fetal vasculature coexisting with anterior segment dysgenesia. / Vasculatura fetal persistente unilateral asociada a disgenesia del segmento anterior.

CASE REPORT: A case is presented of a 4 week-old female neonate with Peters anomaly (PA) and unilateral persistent foetal vasculature (PFV) referred to our centre due to esotropia. At 12 weeks of age, a penetrating keratoplasty and vitrectomy were performed without major complications in the immediate post-operative period. The patient is currently under an intensive treatment for amblyopia and secondary glaucoma. DISCUSSION: Surgical treatment of PFV is controversial, with prevention of amblyopia, phthisis, and glaucoma being the main reasons for it. Patients with unilateral PFV and type II PA could be good candidates for this combined surgical procedure.